1 min read

Abveris to speak at the Future of Drug Discovery and Development Symposium

6/11/19 10:35 AM

Boston, MA - June 11, 2019 - Ryan Kelly, the Associate Director of Business Development at Abveris, will give a talk about our advanced immunization strategies and antibody discovery platform technologies at the Future of Drug Discovery and Development Symposium hosted by ACROBiosystems and Biocytogen.

The symposium will be held on Thursday June 13, 2019 from 1-6PM in Cambridge.

Register for free to attend the symposium on Eventbrite.

Join the symposium to learn more about cutting-edge therapeutic antibody discovery technologies and the latest research in biologics drug development. The conference is free to attend, light refreshments and dinner will be provided.

Confirmed Speakers:

Chun-Nan Chen

CEO and CSO, Single Cell Technology

Qingcong Lin

CEO, Biocytogen Boston Corp

Stephen Gillies

CSO, LinkedUp Bioscience Inc

Johanna Lahdenranta

Director of In Vivo Pharmacology, Bicycle Therapeutics

Ryan Kelly

Associate Director, BD at Abveris, Co-Founder at AbX Biologics

Xiaodong Li

Associate of Patent and Intellectual Property, Choate, Hall & Stewart LLP


Click here to learn more about the symposium.

Event Details & Address:

Thursday June 13, 2019 from 1-6PM

Residence Inn Boston Cambridge

120 Broadway, Six Cambridge Center

Cambridge, MA

Topics: Conferences
Matthew Bartolucci

Written by Matthew Bartolucci